Valuation Mayinglong Pharmaceutical Group Co., LTD.

Stocks

End-of-day quote Shanghai S.E. 2026-10-26			5-day change	1st Jan Change
24.33 ^CNY	+0.16%		-0.98%	-13.11%

08-25	Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-10	China Includes Two Mayinglong Pharmaceutical Products in Essential Medicines List	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025	2026	2027	2028
Market Cap ¹	10,423	11,255	12,070	10,488	-	-
Change	-	7.98%	7.24%	-13.11%	-	-
Enterprise Value (EV)	10,423	11,255	12,070	10,488	10,488	10,488
Change	-	7.98%	7.24%	-13.11%	0%	0%
P/E	-	21.2x	20.7x	15.7x	14.2x	12.8x
PBR	-	2.77x	2.76x	2.21x	1.91x	1.65x
PEG	-	-	2.12x	1.1x	1.3x	1.2x
Capitalization / Revenue	3.32x	3.02x	3.12x	2.5x	2.28x	2.11x
EV / Revenue	0x	0x	0x	2.5x	2.28x	2.11x
EV / EBITDA	-	0x	0x	12.6x	11.3x	10.3x
EV / EBIT	-	0x	0x	13.1x	11.8x	10.8x
EV / FCF	-	0x	-	10.6x	10.4x	9.55x
FCF Yield	-	2.62%	-	9.45%	9.6%	10.5%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	1.23	1.35	1.545	1.715	1.9
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,137	3,728	3,867	4,198	4,606	4,980
EBITDA ¹	-	686.7	791.2	834	926.5	1,014
EBIT ¹	-	666.8	719.9	801	886.5	975
Net income ¹	443.3	528.1	581.5	667.5	739.5	819
Net Debt	-	-	-	-	-	-
Reference price ²	24.18	26.11	28.00	24.33	24.33	24.33
Nbr of stocks (in thousands)	431,054	431,054	431,054	431,054	-	-
Announcement Date	4/12/24	4/2/25	4/24/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MAYINGLONG PHARMACEUTICAL GROUP CO., LTD.	15.72x	-	-	-	1.57B
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	28.12x	7.04x	18.70x	2.12%	400.52B
Weighted average by Cap.	35.22x	8.29x	20.40x	1.8%